Second take on short-supply drug markups exonerates distributors

Rep. Elijah Cummings may have overstated alleged "gray market" price-gouging for drugs in short supply and done a public disservice to small distributors, according to Superior Medical Supply, one of his probe targets. In early October, Cummings cited data from a report published by group purchaser Premier health alliance showing that short-supply drug markups average 650% and have reached 4,500%. Pharmaceutical Commerce reported last week that Premier acknowledged its data showed a markup range of 29% to 729%. Plus, the comparison ignores the "market reality" that prices negotiated by group purchasers are generally 40% to 50% lower than the small distributor cost, says a statement from the National Coalition of Pharmaceutical Distributors. Letter | Story | NCPD release


Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.